MYB PROTEIN BINDS TO HUMAN IMMUNODEFICIENCY VIRUS-1 LONG TERMINAL REPEAT (LTR) SEQUENCES AND TRANSACTIVATES LTR-MEDIATED TRANSCRIPTION

被引:66
作者
DASGUPTA, P [1 ]
SAIKUMAR, P [1 ]
REDDY, CD [1 ]
REDDY, EP [1 ]
机构
[1] WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104
关键词
DNA-protein interactions; Human immunodeficiency virus 1 gene regulation; Nuclear protooncogenes; Transcriptional regulation;
D O I
10.1073/pnas.87.20.8090
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The protooncogene c-myb encodes a nuclear transcription factor that binds to DNA in a sequence-specific manner and transactivates transcription of several viral and cellular genes. The expression of c-myb is induced in mitogen-stimulated peripheral blood lymphocytes and is constitutively expressed in several CD4+ T-cell and myeloid cell lines, all of which constitute excellent targets for human immunodeficiency virus (HIV) infection and replication. We looked for the presence of Myb-binding motifs in human retroviral long terminal repeats (LTKs) and tested for Myb binding to HIV-1 LTR sequences by using a highly purified recombinant Myb protein. Our results show that HIV-1 LTR contains one high-affinity Myb-binding site along with two or more low-affinity binding sites. DNase I protection analysis as well as oligonucleotide competition experiments indicate that this binding is sequence specific. Introduction of purified Myb protein directly into HeLa cells harboring HIV-1 LTR chloramphenicol acetyltransferase vectors indicates that Myb protein transactivates HIV-1 LTR-mediated transcription. Thus, Myb protein binding to HIV LTR sequences may constitute one of the signals that regulates HIV-1 transcription.
引用
收藏
页码:8090 / 8094
页数:5
相关论文
共 37 条
[1]   TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) [J].
ARYA, SK ;
GUO, C ;
JOSEPHS, SF ;
WONGSTAAL, F .
SCIENCE, 1985, 229 (4708) :69-73
[2]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[3]   VIRAL MYB ONCOGENE ENCODES A SEQUENCE-SPECIFIC DNA-BINDING ACTIVITY [J].
BIEDENKAPP, H ;
BORGMEYER, U ;
SIPPEL, AE ;
KLEMPNAUER, KH .
NATURE, 1988, 335 (6193) :835-837
[4]  
BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132
[5]   MOLECULAR-BIOLOGY OF HIV - NEW INSIGHTS INTO THE VIRUS LIFE-CYCLE [J].
CANN, AJ ;
KARN, J .
AIDS, 1989, 3 :S19-S34
[6]  
CHODOSH LA, 1988, CURRENT PROTOCOLS S, V3
[7]   THE EPIDEMIOLOGY OF AIDS - CURRENT STATUS AND FUTURE-PROSPECTS [J].
CURRAN, JW ;
MORGAN, WM ;
HARDY, AM ;
JAFFE, HW ;
DARROW, WW ;
DOWDLE, WR .
SCIENCE, 1985, 229 (4720) :1352-1357
[8]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[9]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193
[10]   FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS [J].
GALLO, RC ;
SALAHUDDIN, SZ ;
POPOVIC, M ;
SHEARER, GM ;
KAPLAN, M ;
HAYNES, BF ;
PALKER, TJ ;
REDFIELD, R ;
OLESKE, J ;
SAFAI, B ;
WHITE, G ;
FOSTER, P ;
MARKHAM, PD .
SCIENCE, 1984, 224 (4648) :500-503